Patent search ap:("Dr. Subhajit Dasgupta") AND inv:"Subhajit Dasgupta" Page 1

1.

发明申请
Identification of SARS-COV2 Spike glycoprotein epitope amino acid sequences recognized by Human class II antigen presenting determinant HLA-DR1 and innate immune responder Toll-like receptor 8 by using computer modeling and molecular docking methods. 有权

公开(公告)号：US20220098245A1

公开(公告)日：2022-03-31

申请号：US17346245

申请日：2021-06-13

Applicant: Dr. Subhajit Dasgupta

Inventor： Subhajit Dasgupta

IPC: C07K14/165

Abstract: The multi-epitope SARS-COV2 Spike peptides are analyzed for their ability to form association or binding complex with HLA-DR1 and human TLR8 by using computer modeling and molecular docking experiments. These peptides are identified as candidates for vaccine development as well as antibody-based immunotherapy.

2.

发明公开
Identification of inhibitor peptides to bind with N-terminal Spike (S) and nonstructural protein (NSP) sequences of SARS-COV2 B.1.617.2 Delta or Omicron variants alone and combination with drug(s) for targeted antiviral therapy 审中-公开

公开(公告)号：US20230250136A1

公开(公告)日：2023-08-10

申请号：US17736755

申请日：2022-05-04

Applicant: Dr. Subhajit Dasgupta

Inventor： Subhajit Dasgupta

IPC: C07K14/165 , A61P31/14

CPC classification number: C07K14/165 , A61P31/14

Abstract: The identified peptide sequences form moderate to strong heterodimeric complexes with SARS-COV2 (B.1.617.2) virus Spike envelope proteins and a range of virus nonstructural protein sequences NSP1-14. These identified peptides are proposed to use in antiviral immunotherapy and supportive combination with chemical compound(s) for chemotherapy. The sequence ID of the identified peptides are, Seq1: ISD1, Seq2: ISD2, Seq3: ISD3, Seq4: ISD4, Seq5: ISD5, Seq6: ISD6, Seq7 Ip2, Seq8: Ip1, Seq9: Ip3, Seq10: Ip5, Seq11: Ip7, Seq12: Ip8, Seq13: Ip9, Seq14: SOI1, Seq15: SOI2, Seq16: SOI5, Seq17: SOI7, Seq18: SOI9, Seq19: SO10, Seq20: SO11.

Patent Agency Ranking